Abstract
Our objective was to adapt the physical health Patient Activation Measure (PAM) for use among people with mental health conditions (PAM-MH). Data came from three studies among people with chronic mental health conditions and were combined in Rasch analyses. The PAM-MH’s psychometric properties equal those of the original 13-item PAM. Test–retest reliability and concurrent validity were good, and the PAM-MH showed sensitivity to change. The PAM-MH appears to be a reliable and valid measure of patient activation among individuals with mental health problems. It appears to have potential for use in assessing change in activation.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Notes
n = 10 for intervention group (2 were missing at follow-up); n = 18 for the control group.
References
Alegria, M., Polo, A., Gao, S., Santana, L., Rothstein, D., Jimenez, A., et al. (2008). Evaluation of a patient activation and empowerment intervention in mental health care. Medical Care, 46, 247–256.
Bartlett, J., Chalk, M., Manderscheid, R. W., & Wattenberg, S. (2006). Finding common performance measures through consensus and empirical analysis: The forum on performance measures in behavioral healthcare (Rep. No. DDHS Pub No. SMA06–4195). Rockville, MD: Substance Abuse and Mental Health Services Administration.
Becker, M. (1998). A US experience: Consumer responsive quality of life measurement. Canadian Journal of Community Mental Health 41–58.
Becker, M., Diamond, R., & Sainfort, F. (1993). A new patient focused index for measuring quality of life in persons with severe and persistent mental illness. Quality of Life Research, 2, 239–251.
Corrigan, P. W., Giffort, D., Rashid, F., Leary, M., & Okeke, I. (1999). Recovery as a psychological construct. Community Mental Health Journal, 35, 231–239.
Diamond, R., & Becker, M. (1999). The Wisconsin quality of life index: A multidimensional model for measuring quality of life. The Journal of Clinical Psychiatry, 60(Suppl 3), 29–31.
Hibbard, J. H., Stockard, J., Mahoney, E. R., & Tusler, M. (2004). Development of the patient activation measure (PAM): Conceptualizing and measuring activation in patients and consumers. Health Services Research, 39, 1005–1026.
Hibbard, J. H., Mahoney, E. R., Stockard, J., & Tusler, M. (2005). Development and testing of a short form of the patient activation measure. Health Services Research, 40, 1918–1930.
Hibbard, J. H., Mahoney, E. R., Stock, R., & Tusler, M. (2007). Self-management and health care utilization: Do increases in patient activation result in improved self-management behaviors? Health Services Research, 42, 1443–1463.
Institute of Medicine, & Committee on Quality Health Care in America. (2001). Crossing the quality chasm: A new health system for the 21st century. Washington, DC: National Academy Press.
Institute of Medicine, Committee on Crossing the Quality Chasm: Adaptation to Mental Health and Addictive Disorders, & Board on Health Care Services. (2006). Improving the quality of health care for mental and substance-use conditions. Washington, DC: The National Academies Press.
McDowell, I., & Newell, C. (1996). Measuring health: A guide to rating scales and questionnaires. New York, New York: Oxford University Press.
Rasch, G. (1960). Probabilistic models for some intelligence and attainment tests (reprint, with Foreword and Afterword by B. D. Wright, Chicago: University of Chicago Press, 1980). Copenhagen, Denmark: Danmarks Paedogogiske Institut.
Shern, D. L., Wilson, N. Z., Coen, A. S., Patrick, D. C., Foster, M., Bartsch, D. A., et al. (1994). Client outcomes II: Longitudinal client data from the Colorado treatment outcome study. Milbank Quarterly, 72, 123–148.
Spitzer, W. O., Dobson, A. J., Hall, J., Chesterman, E., Levi, J., Shepherd, R., et al. (1981). Measuring the quality of life of cancer patients: A concise QL-index for use by physicians. Journal of Chronic Diseases, 34, 585–597.
Tunis, S. L., Croghan, T. W., Heilman, D. K., Johnstone, B. M., & Obenchain, R. L. (1999). Reliability, validity, and application of the medical outcomes study 36- item short-form health survey (SF-36) in schizophrenic patients treated with olanzapine versus haloperidol. Medical Care, 37, 678–691.
Von Korff, M., Gruman, J., & Schaefer, C. (1997). Collaborative management of chronic illness. Annals of Internal Medicine, 127, 1097–1102.
Ware, J. E., Kosinski, M., & Keller, S. D. (1995). SF-12: How to score the SF-12 physical and mental health summary scales. Boston: The Health Institute, New England Medical Center.
Ware, J. E., Jr., Kosinski, M., Turner-Bowker, D. M., & Gandek, B. (2002). How to score Version 2 of the SF-12 Health Survey (With a supplement documenting Version 1). Lincoln, RI: QualityMetric Incorporated.
Wright, B. D., & Masters, G. (1982). Rating scale analysis. Chicago: Mesa Press.
Wright, B. D., & Stone, M. H. (1979). Best test design. Chicago: Mesa Press.
Acknowledgments
This work was supported by the National Institute of Mental Health (R01 MH062321, Recoveries from Severe Mental Illness), Kaiser Foundation Hospitals Community Benefit Initiative, and Portland State University.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Green, C.A., Perrin, N.A., Polen, M.R. et al. Development of the Patient Activation Measure for Mental Health. Adm Policy Ment Health 37, 327–333 (2010). https://doi.org/10.1007/s10488-009-0239-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10488-009-0239-6